An unprecedented legal action by the pharmaceutical industry against the government could reach the High Court within the next few …
Antisoma drops ovarian cancer drugCancer drug developer Antisoma says new data from its Phase II trial of ASA404 showed that …
There is a much-quoted statistic, which has become so hackneyed that it's largely ignored these days, but while you are …
A review of the NHS in London has recommended setting up a network of 150 'polyclinics' to take on much …
The FDA has approved Novartis' Exelon Patch, the first ever skin patch treatment for Alzheimer's disease.Novartis said the once-daily treatment …
The world’s largest private healthcare PR firm Chandler Chicco Agency has been bought out by US marketing group inVentiv Health …
Piramed and Domainex are among the cutting-edge companies which have been recognised as the best of the UKs biotech sector.UK …
Janssen-Cilag's once-daily schizophrenia treatment, Invega, has been granted European approval, making it the first oral, prolonged-release drug for the condition …
Patients with the deadly type of lung cancer called mesothelioma will now be able to receive Lilly's Alimta after NICE …
Vorsprung durch technik? Technological advances have allowed employees to spend increasing amounts of time working remotely away from the office. …
Genzyme says osteoarthritis treatment misses trial goalsGenzyme has reported that its trial of hylastan in treating pain in patients with …
The UK pharmaceutical industry has announced plans to take legal action against the government over the way it controls how …
One of the world's leading surgeons, Professor Ara Darzi, has been handed the task of conducting a major new review …
Dementia is being given far too low a priority by health and social services in the UK, despite a rapid …
Michael Moore's new film about the US healthcare system, Sicko, is stirring controversy following its release in cinemas across America …
Roche has launched a hostile takeover bid for cancer diagnostics company Ventana, offering to pay around $3 billion for the …
Glitz, glamour and a certain type of buttoned-down cool came together at the annual Best of Health Awards, which this …
Onyx Health has been appointed to promote UCB Pharma's narcolepsy treatment Xyrem in the UK.The orphan drug expanded its European …
Biovest reports encouraging interim results for cancer vaccineBiovest International, a majority-owned subsidiary of Accentia Biopharmaceuticals, has revealed positive interim data …
The global clinical trials market continues to grow and is currently worth an estimated $10 billion; so much so that …